title: The role of the nurse practitioner in the diagnosis and early management of type 2 diabetes.
abstract: OBJECTIVE
  To review the early diagnosis and early effective treatment of type 2 diabetes and its role in reducing the risk of complications. This article discusses the diagnosis of T2D and the initial stages of disease management with oral monotherapy.
  
  
  METHODS
  Extensive literature review of textbooks and clinical, medical, and nursing journals.
  
  
  CONCLUSIONS
  There are clear evidence-based recommendations for disease management in the early stages of T2D, with therapy focusing on implementation of lifestyle changes and use of pharmacologic monotherapy. A vital part of early T2D treatment is patient education, which can lay the foundation for treatment throughout the disease continuum. The lifestyle changes recommended for management of T2D can be difficult for patients to sustain, and treatment regimens are often complex.
  
  
  CONCLUSIONS
  Type 2 diabetes (T2D) is a progressive disease, associated with a long-term risk of morbidity and mortality. Therefore, it is important that treatment is individualized, and that ongoing support is provided to maximize the possibility of achieving treatment goals. Current standards for T2D treatment are designed for a patient-centered treatment approach managed by team of healthcare practitioners, in which the nurse practitioner (NP) is central.
authors.affiliation: Customized Diabetes Education, New York, New York, USA. carobertson@mednet.ucla.edu
authors.forename: Carolyn
authors.initials: C
authors.lastname: Robertson
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy / Q000451:nursing*; D019468:Disease Management; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use; D024802:Nurse's Role; D009733:Nursing Diagnosis / Q000379:methods*; D010353:Patient Education as Topic; D012306:Risk; D013997:Time Factors
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin